Retatrutide is a newly developed therapy that acts as a potent GLP-1 receptor stimulator. This revolutionary approach holds significant potential for managing type 2 diabetes. By replicating the actions of natural GLP-1, Retatrutide enhances insulin secretion and limits glucagon release, leading to improved glycemic control. Clinical trials have de